Company / Interest Expense per Share
ADC Therapeutics SA Interest Expense per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.16
FY2025
5-year range
$0.16 / $0.56
FY2023-FY2025
Trend
-70.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.46 to $0.16 over the past 2 years.
Based on SEC 10-K filings.
0.16 in FY2025.
Improved from $0.46 to $0.16 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share decreased 70.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.16 | -70.8% |
| FY2024 | $0.56 | +23.6% |
| FY2023 | $0.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026